ARTA
ECYT

A.R.T. Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

A.R.T. Advisors’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-27,156
Closed -$38K – 1847
2017
Q3 		$38K Sell
27,156
-127,975
-82% -$178K ﹤0.01% 1270
2017
Q2 		$232K Buy
155,131
+115,011
+287% +$247K 0.01% 1106
2017
Q1 		$103K Buy
40,120
+15,020
+60% +$34.7K ﹤0.01% 1266
2016
Q4 		$64K Buy
+25,100
New +$72.1K ﹤0.01% 1197
2016
Q3 		– Sell
-30,273
Closed -$97K – 1441
2016
Q2 		$97K Sell
30,273
-63,700
-68% -$233K ﹤0.01% 1209
2016
Q1 		$291K Buy
93,973
+10,900
+13% +$35.6K 0.01% 1057
2015
Q4 		$333K Buy
83,073
+46,502
+127% +$214K 0.02% 1021
2015
Q3 		$167K Buy
36,571
+8,913
+32% +$46.6K 0.01% 1194
2015
Q2 		$143K Sell
27,658
-3,700
-12% -$22.2K ﹤0.01% 1325
2015
Q1 		$196K Buy
+31,358
New +$181K 0.01% 1237
2014
Q4 		– Sell
-311,217
Closed -$1.89M – 1788
2014
Q3 		$1.89M Buy
311,217
+5,242
+2% +$35.8K 0.09% 312
2014
Q2 		$2.02M Buy
305,975
+284,683
+1,337% +$3.21M 0.11% 281
2014
Q1 		$506K Sell
21,292
-16,472
-44% -$239K 0.03% 737
2013
Q4 		$403K Sell
37,764
-7,457
-16% -$82.3K 0.02% 862
2013
Q3 		$602K Buy
45,221
+8,751
+24% +$138K 0.03% 698
2013
Q2 		$478K Buy
+36,470
New +$492K 0.02% 892

Other funds holding ECYT

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

A.R.T. Advisors's ECYT Position: Q4 2017 in Review

A.R.T. Advisors sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2017, closing a stake of 27,156 shares — an estimated $38K sold.

A.R.T. Advisors first reported a position in ECYT in Q2 2013 and held it in 16 quarters. The position peaked at $2.02M in Q2 2014. 71 funds tracked by Wall St. Rank hold ECYT as of Q4 2017.

  • A.R.T. Advisors reported no remaining Endocyte, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 27,156 Endocyte, Inc. Common Stock shares in Q4 2017, an estimated $38K.
  • A.R.T. Advisors first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • A.R.T. Advisors's Endocyte, Inc. Common Stock position peaked at $2.02M in Q2 2014.
  • 71 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2017.

Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.